Page 8 of 13 – SEC Filing
| CUSIP No. 19249H103 | 13G | Page 8 of 13 Pages |
| Item 1(a) | Name of Issuer |
Coherus BioSciences, Inc.
| Item 1(b) | Address of Issuer’s Principal Executive Offices 333 Twin Dolphin Drive, Suite 600, Redwood City, California 94065 |
| Item 2(a) | Name of Person Filing This Schedule 13G is being jointly filed by Partner Fund Management, L.P. (“PFM”), Partner Fund Management GP, LLC (“PFM-GP”), Partner Investment Management, L.P. (“PIM”), Partner Investment Management GP, LLC (“PIM-GP”), Brian D. Grossman (“Grossman”) and Christopher M. James (“James” and, collectively with PFM, PFM-GP, PIM, PIM-GP and Grossman, the “Reporting Persons”) with respect to shares of common stock (and options to purchase common stock) of the above-named issuer owned by PFM Healthcare Emerging Growth Master Fund, L.P., a Cayman Islands limited partnership (“HEGM”), PFM Healthcare Master Fund, L.P., a Cayman Islands limited partnership (“HCM”), PFM Healthcare Opportunities Master Fund, L.P., a Cayman Islands limited partnership (“HCOPP”), PFM Healthcare Long Master Fund, L.P., a Cayman Islands limited partnership (“HCLM”), PFM Oncology Opportunities Master Fund, L.P., a Cayman Islands limited partnership (“ONCOPP”), and PFM Healthcare Principals Fund, L.P., a Delaware limited partnership (“HCP” and, collectively with HEGM, HCM, HCOPP, HCLM and ONCOPP, the “Funds”). |
PFM is the investment advisor for
HEGM, HCM, HCOPP, HCLM and, ONCOPP. PIM is the investment advisor for HCP. PFM-GP and PIM-GP are, respectively, the general partners
of PFM and PIM. Grossman is the portfolio manager for the health care strategy for the Funds. James is the portfolio manager for
the diversified strategy for the Funds. Grossman and James are co-managing members of PFM-GP and PIM-GP.
The filing of this statement shall
not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement
other than the securities actually owned by such person (if any).
| Item 2(b) | Address of Principal Business Office The address of the principal business office of each of the Reporting Persons is c/o Partner Fund Management, L.P., 4 Embarcadero Center, Suite 3500, San Francisco, CA 94111. |
| Item 2(c) | Citizenship Each of PFM and PIM is organized as a limited partnership under the laws of the State of Delaware. Each of PFM-GP and PIM-GP is organized as a limited liability company under the laws of the State of Delaware. Each of Grossman and James is a U.S. citizen. | |
| Item 2(d) | Title of Class of Securities | |
| Common stock, $0.0001 par value | ||
| Item 2(e) | CUSIP Number | |
| 19249H103 |
Follow Coherus Oncology Inc. (NASDAQ:CHRS)
Follow Coherus Oncology Inc. (NASDAQ:CHRS)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
